Patient with Von Hippel-Lindau disease diagnosed with Renal Cell Carcinoma
DOI:
https://doi.org/10.33448/rsd-v13i12.47548Keywords:
VHL disease; Autosomal dominant; Renal cell carcinoma.Abstract
Von Hippel-Lindau disease is an autosomal dominant hereditary disorder caused by a germline mutation in the VHL gene. Those mutations lead to the development of multiple benign and malignant tumors, including renal cell carcinoma (RCC). VHL disease is the most common risk factor for hereditary RCC, presenting in 1 in 36,000 live births. Patients with VHL disease are at high risk of early and multiple clear cell RCC; approximately two-thirds will present several renal cysts and RCC during their lifetimes. RCCs are the leading cause of death in patients with VHL, and median overall survival in these patients is around 50 years. The purpose of the present study is to present a clinical case report of a 54-year-old Indonesian male patient who had a stiff neck, followed by constant tingling in the right arm. The patient was subsequently diagnosed with VHL disease based on clinical diagnostic criteria, which included central nervous system (CNS) hemangioblastoma, pancreatic cyst, and RCC. Early recognition and treatment remain the mainstay of VHL disease management. Treatment decisions for RCC in VHL depend on tumor size and growth kinetics of each lesion, as those parameters determine the risk of metastatic disease. The main therapeutic goal to deal with RCCs in patients with VHL disease is to remove as many RCCs as possible while preserving renal function.
References
Akioka, T., Terada, N., Takamori, H., Kamimura, T., Mukai, S., & Kamoto, T. (2022). A case of von Hippel-Lindau disease with renal cell carcinoma treated by partial nephrectomy with pre- and post-surgical axitinib therapy. Urology Case Reports, 40, 1-3. https://doi.org/10.1016/j.eucr.2022.101935
Bhuyan, M., Saha, D., Baishya, B. K., & Ghanghoria, A. (2020). A case of von Hippel-Lindau disease with multi-organ involvement: A rare case report. International Surgery Journal, 7(5), 1684-7. https://doi.org/10.18203/2349-2902.isj20201933
Binderup, M. L. M., Smerdel, M., Borgwadt, L., Nielsen, S. S. B., Madsen, M. G., Moller, H. U., Kiilgaard, J. F., Friis-Hansen, L., Harbud, V., Cortnum, S., Owen, H., Gimsing, S., Juhl, H. A. F., Munthe, S., Geilswijk, M., Rasmussen, A. K., Moldrup, U., & Graumann, O. (2022). von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance. Genetics, 104538. https://doi.org/10.1016/j.genetics.2022.104538
Carrion, D. M., Linares-Espinos, E., Gonzales, E. R., Bazan, A. A., Alvarez-Maestro, M., & Martinez-Pineiro, L. (2020). Invasive management of renal cell carcinoma in von Hippel-Lindau disease. Central European Journal of Urology, 73, 167-72. https://doi.org/10.5173/ceju.2020.0102
Chahoud, J., McGettigan, M., Parikh, N., Boris, R. S., Iliopoulos, O., Rathmell, W. K., Daniels, A. B., Jonasch, E., Spiess, P. E. (2021). Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease. World Journal of Urology, 39(7), 2409-15. https://doi.org/10.1007/s00345-020-03559-2
Choueiri, T. K., Tomczak, P., Park, S. H., Venugopal, B., Ferguson, T., Chang, Y. H., Hajek, J., Symeonides, S. N., Lee, J. L., & Sarwar, N. (2021). Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma. New England Journal of Medicine, 385(8), 683-94. https://doi.org/10.1056/NEJMoa2106273
Cinque, A., Minnei, R., Floris, M., & Trevisani, F. (2022). The clinical and molecular features in the VHL renal cancers: Close or distant relatives with sporadic clear cell renal cell carcinoma? Cancers, 14, 1-20. https://doi.org/10.3390/cancers14010120
Estrela, C. (2018). Metodologia Científica: Ciência, Ensino, Pesquisa. Editora Artes Médicas.
Kim, E., & Zschiedrich, S. (2018). Renal cell carcinoma in von Hippel-Lindau disease: From tumor genetics to novel therapeutic strategies. Frontiers in Oncology, 6(16), 1-9. https://doi.org/10.3389/fonc.2016.00158
Kim, H. C., Lee, J. S., Kim, S. H., So, H. S., Woo, C. Y., & Lee, J. L. (2013). Sunitinib treatment for metastatic renal cell carcinoma in patients with von Hippel-Lindau disease. Cancer Research and Treatment, 45(4), 349-53. https://doi.org/10.4143/crt.2013.45.4.349
Maher, E. R., Adlard, J., Barwell, J., Brady, A. F., Brennan, P., Cook, J., Crawford, G. S., Dabir, T., Davidson, R., Dyer, R., Harrison, R., Forde, C., Halliday, D., Hanson, H., Hay, E., Higgs, J., Jones, M., Miedzybrodzka, Z., Ong, K. R., Pelz, F., Ruddy, D., Snape, K., Whitworth, J., & Sandford, R. N. (2022). Evaluation of tumour surveillance protocol and outcomes in von Hippel-Lindau disease in a national health service. British Journal of Cancer, 126, 1339-45. https://doi.org/10.1038/s41416-022-01885-7
Motzer, R., Alekseev, B., Rha, S. Y., Porta, C., Eto, M., Powles, T., Grunwald, V., Hutson, T. E., Kopyltsov, E., Mendez-Vidal, M. J., Kozlov, V., Alyasova, A., Hong, S. H., Kapoor, A., Merchan, J. R. (2021). Lenvatinib plus pembrolizumab or everolimus for advanced renal cell carcinoma. New England Journal of Medicine, 384(14), 1289-300. https://doi.org/10.1056/NEJMoa2035718
Northrup, B. E., Jokerst, C. E., Grubb, L. L., Menias, C. O., Khanna, G., & Siegel, C. L. (2012). Hereditary renal tumor syndromes: Imaging findings and management strategies. American Journal of Roentgenology, 199, 1294-304. https://doi.org/10.2214/AJR.12.9536
National Comprehensive Cancer Network (NCCN). (2023). NCCN clinical practice guidelines in oncology: Kidney cancer (Version 1.2024). National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf. Cited on July 10, 2023.
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Santa Maria/RS. Ed. UAB/NTE/UFSM.
Reddy, J. V., Reddy, K. V., & Reddy, G. R. (2020). A rare case of Von Hippel-Lindau disease. International Journal of Contemporary Medicine, Surgery and Radiology, 5(4), 77-79. https://www.ijcmsr.com
Thulung, S., Baniya, A., Paudel, S. S., Devkota, A., & Shrestha, S. (2020). Von Hippel-Lindau syndrome—A case report. Journal of Brain and Spine Foundation Nepal, 1(1), 25-8. https://doi.org/10.3126/jbsfn.v1i1.29957
Zhang, G., Hou, Y., Jia, W., Yang, J., & Xu, Y. (2016). Metastasis of renal cell carcinoma to hemangioblastoma of the spinal cord in von Hippel-Lindau disease: Report of a case and review of literature. International Journal of Clinical and Experimental Pathology, 9(8), 8730-5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971952/
Zhang, L., Xu, B., Wang, Y., Liu, C., Lu, K., Huang, Y., Liu, N., Zhang, X., Chen, S., & Chen, M. (2015). Advanced renal cell carcinoma associated with von Hippel-Lindau disease: A case report and review of the literature. Oncology Letters, 10, 1087-90. https://doi.org/10.3892/ol.2015.3426
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Lindia Prabhaswari; I Wayan Losen Adnyana
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
